Onconetix Announces Reverse Stock Split
Globe Newswire•26/10/2026•17:03 ET
0
Key Highlights
- ➤1-for-10 reverse split effective November 6, 2026, at 12:01 a.m. Eastern Time
- ➤Outstanding shares expected to fall from 5,886,774 to approximately 588,677
- ➤Onconetix (ONCO) will continue trading on Nasdaq under its existing symbol
- ➤Authorized common shares remain 250,000,000; par value stays $0.00001
CINCINNATI, Ohio, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”), today announced that its Board of Directors has approved a one-for-ten (1-for-10) reverse stock split of the Company’s outstanding common stock. The reverse split is expected to become effective at 12:01 a.m. Eastern Time on November 6, 2026. The Company’s common stock has been assigned a new CUSIP number, 68237Q500, in connection with the reverse stock split.
Following the reverse split, every ten (10) shares of Onconetix common stock will be automatically exchanged into one share of common stock. The Company’s common stock will continue to trade on Nasdaq under the symbol “ONCO”.
Get started
Create a free account to read the full story.